title: Secondary solid cancer screening following hematopoietic cell transplantation.
abstract: Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and without reaching a plateau overtime. A working group was established through the Center for International Blood and Marrow Transplant Research and the European Group for Blood and Marrow Transplantation with the goal to facilitate implementation of cancer screening appropriate to HCT recipients. The working group reviewed guidelines and methods for cancer screening applicable to the general population and reviewed the incidence and risk factors for secondary cancers after HCT. A consensus approach was used to establish recommendations for individual secondary cancers. The most common sites include oral cavity, skin, breast and thyroid. Risks of cancers are increased after HCT compared with the general population in skin, thyroid, oral cavity, esophagus, liver, nervous system, bone and connective tissues. Myeloablative TBI, young age at HCT, chronic GVHD and prolonged immunosuppressive treatment beyond 24 months were well-documented risk factors for many types of secondary cancers. All HCT recipients should be advised of the risks of secondary cancers annually and encouraged to undergo recommended screening based on their predisposition. Here we propose guidelines to help clinicians in providing screening and preventive care for secondary cancers among HCT recipients.
authors.affiliation: Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Inamoto
authors.affiliation: Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institute of Health (NIH), Bethesda, MD, USA.
authors.forename: N N
authors.initials: NN
authors.lastname: Shah
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: B N
authors.initials: BN
authors.lastname: Savani
authors.affiliation: Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: B E
authors.initials: BE
authors.lastname: Shaw
authors.affiliation: Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: Abraham
authors.affiliation: Department of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
authors.forename: I A
authors.initials: IA
authors.lastname: Ahmed
authors.affiliation: Section of Hematology Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
authors.forename: G
authors.initials: G
authors.lastname: Akpek
authors.affiliation: 1] Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan [2] Nagoya University Graduate School of Medicine, Nagoya, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Atsuta
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors.forename: K S
authors.initials: KS
authors.lastname: Baker
authors.affiliation: Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
authors.forename: G W
authors.initials: GW
authors.lastname: Basak
authors.affiliation: Department of Pediatric Hematology/Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Bitan
authors.affiliation: Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: DeFilipp
authors.affiliation: Colorado Blood Cancer Institute at Presbyterian/St Luke's Medical Center, Denver, CO, USA.
authors.forename: T K
authors.initials: TK
authors.lastname: Gregory
authors.affiliation: Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
authors.forename: H T
authors.initials: HT
authors.lastname: Greinix
authors.affiliation: Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: M
authors.initials: M
authors.lastname: Hamadani
authors.affiliation: Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: B K
authors.initials: BK
authors.lastname: Hamilton
authors.affiliation: Division of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St Louis, St Louis, MO, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Hayashi
authors.affiliation: Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Jacobsohn
authors.affiliation: Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
authors.forename: R T
authors.initials: RT
authors.lastname: Kamble
authors.affiliation: Division of Hematology-Oncology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Kasow
authors.affiliation: Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
authors.forename: N
authors.initials: N
authors.lastname: Khera
authors.affiliation: Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
authors.forename: H M
authors.initials: HM
authors.lastname: Lazarus
authors.affiliation: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: A K
authors.initials: AK
authors.lastname: Malone
authors.affiliation: Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy.
authors.forename: M T
authors.initials: MT
authors.lastname: Lupo-Stanghellini
authors.affiliation: Department of Pediatric Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: S P
authors.initials: SP
authors.lastname: Margossian
authors.affiliation: Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA.
authors.forename: L S
authors.initials: LS
authors.lastname: Muffly
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
authors.forename: M
authors.initials: M
authors.lastname: Norkin
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worchester, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Ramanathan
authors.affiliation: Imperial College, London, UK.
authors.forename: N
authors.initials: N
authors.lastname: Salooja
authors.affiliation: University Hospital of Leuven, Leuven, Belgium.
authors.forename: H
authors.identifier: 0000000275688239
authors.initials: H
authors.lastname: Schoemans
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Wingard
authors.affiliation: Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, USA.
authors.forename: B
authors.initials: B
authors.lastname: Wirk
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA.
authors.forename: W A
authors.initials: WA
authors.lastname: Wood
authors.affiliation: Royal Adelaide Hospital/SA Pathology and School of Medicine, University of Adelaide, Adelaide, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Yong
authors.affiliation: Department of Pediatric Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: C N
authors.initials: CN
authors.lastname: Duncan
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors.forename: M E D
authors.initials: ME
authors.lastname: Flowers
authors.affiliation: Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: N S
authors.initials: NS
authors.lastname: Majhail
mesh_terms: D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008403:Mass Screening; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000453:epidemiology; D009928:Organ Specificity; D012307:Risk Factors
references.citation: Curr Opin Oncol. 2011 May;23(3):265-70
references.pmid: 21415748
references.citation: Blood. 2008 Jan 15;111(2):939-44
references.pmid: 17911386
references.citation: Leukemia. 2015 Feb;29(2):441-7
references.pmid: 24962016
references.citation: Hepatology. 2011 Mar;53(3):1020-2
references.pmid: 21374666
references.citation: J Clin Oncol. 1998 Jan;16(1):330-7
references.pmid: 9440761
references.citation: Obstet Gynecol. 2011 Mar;117(3):742-6
references.pmid: 21343791
references.citation: Bone Marrow Transplant. 2005 Jul;36(2):115-21
references.pmid: 15908969
references.citation: N Engl J Med. 1997 Mar 27;336(13):897-904
references.pmid: 9070469
references.citation: World J Gastroenterol. 2014 Oct 14;20(38):13842-62
references.pmid: 25320521
references.citation: J Clin Oncol. 2010 Feb 20;28(6):1011-6
references.pmid: 20065176
references.citation: J Med Screen. 2012;19 Suppl 1:5-13
references.pmid: 22972806
references.citation: Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1913-9
references.pmid: 24962841
references.citation: Blood. 2004 Sep 15;104(6):1898-906
references.pmid: 15172972
references.citation: Lancet. 2012 Nov 17;380(9855):1778-86
references.pmid: 23117178
references.citation: JAMA. 2006 May 10;295(18):2164-7
references.pmid: 16684987
references.citation: J Am Acad Dermatol. 2014 Apr;70(4):637-43
references.pmid: 24521828
references.citation: J Clin Oncol. 1995 Oct;13(10):2540-6
references.pmid: 7595705
references.citation: J Clin Oncol. 2011 Nov 1;29(31):4096-104
references.pmid: 21969511
references.citation: Am J Med. 2002 Oct 15;113(6):499-505
references.pmid: 12427500
references.citation: N Engl J Med. 1975 Dec 4;293(23):1164-7
references.pmid: 1186789
references.citation: N Engl J Med. 1975 Dec 4;293(23):1167-70
references.pmid: 171569
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: J Cancer Res Clin Oncol. 2009 May;135(5):731-8
references.pmid: 19002497
references.citation: Cancer. 2014 Sep 1;120(17):2728-34
references.pmid: 25044313
references.citation: Eur J Pediatr. 2014 Sep;173(9):1137-46
references.pmid: 24659311
references.citation: Bone Marrow Transplant. 2012 Jan;47(1):95-100
references.pmid: 21358690
references.citation: N Engl J Med. 2009 Mar 26;360(13):1310-9
references.pmid: 19297565
references.citation: Arch Intern Med. 2009 Feb 23;169(4):351-6
references.pmid: 19237718
references.citation: N Engl J Med. 2014 Nov 6;371(19):1813-20
references.pmid: 25372089
references.citation: J Clin Oncol. 2013 Jul 1;31(19):2469-76
references.pmid: 23690411
references.citation: Radiat Res. 2009 Feb;171(2):155-63
references.pmid: 19267540
references.citation: Dig Liver Dis. 2011 Feb;43(2):89-95
references.pmid: 20739232
references.citation: Curr Opin Infect Dis. 2008 Aug;21(4):399-408
references.pmid: 18594293
references.citation: Eur J Cancer. 2005 Jan;41(2):216-24
references.pmid: 15661545
references.citation: Ann Intern Med. 2012 Dec 4;157(11):808-16
references.pmid: 23208168
references.citation: Blood. 2005 May 15;105(10):3802-11
references.pmid: 15687239
references.citation: N Engl J Med. 1991 Jul 18;325(3):171-82
references.pmid: 1805813
references.citation: Am J Clin Pathol. 2012 Apr;137(4):516-42
references.pmid: 22431528
references.citation: Biol Blood Marrow Transplant. 2014 Nov;20(11):1777-84
references.pmid: 25042734
references.citation: N Engl J Med. 1992 Dec 3;327(23):1649-62
references.pmid: 1435901
references.citation: CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62
references.pmid: 24114568
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):49-54
references.pmid: 14744732
references.citation: Bone Marrow Transplant. 2014 May;49(5):691-8
references.pmid: 24535126
references.citation: Ann Oncol. 2014 Feb;25(2):435-41
references.pmid: 24399081
references.citation: Liver Int. 2007 Dec;27(10):1394-401
references.pmid: 17927713
references.citation: J Clin Oncol. 2001 Jan 15;19(2):464-71
references.pmid: 11208840
references.citation: Ann Intern Med. 2014 Jan 7;160(1):55-60
references.pmid: 24276469
references.citation: Clin Cancer Res. 2009 Apr 1;15(7):2219-21
references.pmid: 19293253
references.citation: J Natl Cancer Inst. 2009 Jun 3;101(11):806-13
references.pmid: 19470947
references.citation: Ann Intern Med. 1999 Nov 16;131(10):738-44
references.pmid: 10577296
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2157-66
references.pmid: 15598775
references.citation: JAMA. 2008 May 14;299(18):2151-63
references.pmid: 18477782
references.citation: Am J Epidemiol. 2014 Sep 1;180(5):508-17
references.pmid: 25008104
references.citation: Obstet Gynecol Clin North Am. 2013 Jun;40(2):339-57
references.pmid: 23732035
references.citation: Biol Blood Marrow Transplant. 2013 Oct;19(10):1498-501
references.pmid: 23906634
references.citation: Blood. 2009 Jan 29;113(5):1175-83
references.pmid: 18971419
references.citation: Bone Marrow Transplant. 2013 Mar;48(3):363-8
references.pmid: 22964594
references.citation: Br J Dermatol. 2006 Mar;154(3):472-7
references.pmid: 16445778
references.citation: Bone Marrow Transplant. 2003 Nov;32(9):915-23
references.pmid: 14561993
references.citation: Biol Blood Marrow Transplant. 2008 Sep;14(9):1072-5
references.pmid: 18721771
references.citation: J Urol. 2005 Nov;174(5):1819-22; discussion 1822
references.pmid: 16217294
references.citation: Eur J Haematol. 2006 Aug;77(2):114-9
references.pmid: 16856906
references.citation: Biol Blood Marrow Transplant. 2012 Mar;18(3):348-71
references.pmid: 22178693
references.citation: JAMA. 2013 Oct 2;310(13):1353-68
references.pmid: 24084921
references.citation: J Clin Oncol. 2013 Jul 10;31(20):2607-18
references.pmid: 23733771
references.citation: N Engl J Med. 2009 Mar 26;360(13):1320-8
references.pmid: 19297566
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: J Clin Oncol. 2003 May 15;21(10):1922-7
references.pmid: 12743144
references.citation: Biol Blood Marrow Transplant. 2010 Aug;16(8):1033-6
references.pmid: 20302962
references.citation: Cancer. 1996 May 15;77(10):2109-16
references.pmid: 8640678
references.citation: Curr Oncol. 2014 Aug;21(4):e531-40
references.pmid: 25089104
references.citation: J Clin Oncol. 2006 Mar 1;24(7):1119-26
references.pmid: 16461782
references.citation: Blood. 2011 Jan 6;117(1):316-22
references.pmid: 20926773
references.citation: J Clin Oncol. 2003 Apr 1;21(7):1352-8
references.pmid: 12663726
references.citation: J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
references.pmid: 14652239
references.citation: Lancet. 1999 Aug 28;354(9180):723-9
references.pmid: 10475183
references.citation: Clin Infect Dis. 2014 Apr;58(7):997-1002
references.pmid: 24363331
references.citation: Cancer. 2007 Jan 1;109(1):84-92
references.pmid: 17131350
references.citation: Cancer. 2009 Jun 1;115(11):2523-30
references.pmid: 19382202
references.citation: Ann Oncol. 2012 Jul;23(7):1813-8
references.pmid: 22104573
references.citation: J Clin Oncol. 2007 Jun 10;25(17):2449-54
references.pmid: 17557958
references.citation: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720
references.pmid: 23440794
references.citation: CA Cancer J Clin. 2013 Mar-Apr;63(2):88-105
references.pmid: 23378235